Peptides for Cancer & Oncology
Peptides studied in oncology, tumor management, and related endocrine conditions.
9 peptides
Degarelix (Firmagon)
FDA ApprovedFDA-approved (NDA022201, 2008) synthetic decapeptide GnRH antagonist for advanced prostate cancer that achieves castrate testosterone levels within...
Goserelin (Zoladex)
FDA ApprovedFDA-approved synthetic decapeptide GnRH agonist marketed as Zoladex, used for prostate cancer, breast cancer, endometriosis, and endometrial thinning...
Histrelin (Supprelin LA, Vantas)
FDA ApprovedFDA-approved synthetic nonapeptide GnRH agonist delivered as a 50 mg subcutaneous hydrogel implant (Supprelin LA for central precocious puberty,...
Lanreotide (Somatuline Depot)
FDA ApprovedAn FDA-approved long-acting somatostatin analog (brand: Somatuline Depot) indicated for acromegaly, gastroenteropancreatic neuroendocrine tumors...
Leuprolide (Lupron)
FDA ApprovedFDA-approved synthetic GnRH agonist (brand: Lupron, Lupron Depot, Eligard, Vabrinty) used for advanced prostate cancer, endometriosis, uterine...
Octreotide (Sandostatin, Sandostatin LAR, Mycapssa, Bynfezia Pen)
FDA ApprovedOctreotide is an FDA-approved synthetic somatostatin analogue that suppresses growth hormone, IGF-1, and gastrointestinal hormones, used primarily...
Signifor / Signifor LAR (pasireotide)
FDA ApprovedPasireotide (Signifor) is an FDA-approved injectable cyclohexapeptide somatostatin analog with high affinity for SSTR5, indicated for Cushing's...
Triptorelin (Trelstar / Triptodur / Decapeptyl / Diphereline)
FDA ApprovedTriptorelin is an FDA-approved synthetic GnRH superagonist decapeptide that produces medical castration through pituitary GnRH receptor...
Thymosin Alpha-1
Moderate EvidenceAn endogenous 28-amino acid thymic peptide that modulates innate and adaptive immunity through Toll-like receptor signaling, enhancing dendritic cell...